THOMAS DOOLIN: Open Payments
NPI 1043347784 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 16 payments from 6 companies in 2025. Trend: 2023 $1,629 · 2024 $1,707 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $1,039 |
| Amgen Inc. | 2 | $240 |
| Novo Nordisk Inc | 1 | $119 |
| Lilly USA, LLC | 1 | $118 |
| ABBVIE INC. | 1 | $58 |
| PFIZER INC. | 1 | $19 |
Products named: BREZTRI, AIRSUPRA, REPATHA, FARXIGA, Wegovy, ZEPBOUND, VRAYLAR, ZAVZPRET.
Industry payments across NY — which companies pay providers there.
